» Articles » PMID: 39498368

End-to-end SARS-CoV-2 Transmission Risks in Sport: Current Evidence and Practical Recommendations

Overview
Specialty Orthopedics
Date 2024 Nov 5
PMID 39498368
Authors
Affiliations
Soon will be listed here.
Abstract

The coronavirus disease 2019 (COVID-19) pandemic has caused disruption to professional and recreational sports across the world. The SARS-CoV-2 virus can be transmitted by relatively large respiratory droplets that behave ballistically, and exhaled aerosol droplets, which potentially pose a greater risk. This review provides a summary of end-to-end SARS-CoV-2 transmission risk factors for sport and an overview of transmission mechanisms to be considered by all stakeholders. The risk of SARS-CoV-2 transmission is greatest indoors, and primarily influenced by the ventilation of the environment and the close proximity of individuals. The SARS-CoV-2 transmission risks outdoors, e.g. via water, and from fomites, appear less than initially thought. Mitigation strategies include good end-to-end scenario planning of activities to optimise physical distancing, face mask wearing and hygiene practice of individuals, the environment and equipment. The identification and removal of infectious individuals should be undertaken by means of the taking of temperature and COVID-19 symptom screening, and the use of diagnostic monitoring tests to identify asymptomatic individuals. Using adequate video footage, data from proximity technology and subject interviews, the identification and isolation of 'close contacts' should also be undertaken to limit SARS-CoV-2 transmission within sporting environments and into the wider community. Sports should aim to undertake activities outdoors where possible, given the lower SARS-CoV-2 transmission risk, in comparison to indoor environments.

References
1.
Kampert M, Singh T, Finet J, Van Iterson E . Impact of wearing a facial covering on aerobic exercise capacity in the COVID-19 era: is it more than a feeling?. Clin Res Cardiol. 2020; 109(12):1595-1596. PMC: 7444164. DOI: 10.1007/s00392-020-01725-7. View

2.
Lee S, Meyler P, Mozel M, Tauh T, Merchant R . Asymptomatic carriage and transmission of SARS-CoV-2: What do we know?. Can J Anaesth. 2020; 67(10):1424-1430. PMC: 7266417. DOI: 10.1007/s12630-020-01729-x. View

3.
Beggs C, Avital E . A psychrometric model to assess the biological decay of the SARS-CoV-2 virus in aerosols. PeerJ. 2021; 9:e11024. PMC: 7934646. DOI: 10.7717/peerj.11024. View

4.
Wang X, Li J, Jin M, Zhen B, Kong Q, Song N . Study on the resistance of severe acute respiratory syndrome-associated coronavirus. J Virol Methods. 2005; 126(1-2):171-7. PMC: 7112909. DOI: 10.1016/j.jviromet.2005.02.005. View

5.
Li J, Lam D, Chen Y, Ting D . Novel Coronavirus disease 2019 (COVID-19): The importance of recognising possible early ocular manifestation and using protective eyewear. Br J Ophthalmol. 2020; 104(3):297-298. DOI: 10.1136/bjophthalmol-2020-315994. View